CEO statement for website
“We here at Cromos Pharma are delighted to be celebrating 15 years of excellence in clinical research.
It is hard to believe just how far Cromos Pharma has come in these 15 years. What started as an idea between two colleagues to create a company that could help develop innovative new medical products and treatments has grown into a dynamic international CRO with over 120 employees.
From small beginnings in one modest office, Cromos Pharma has grown both in size and reach. To date, we have conducted more than 250 clinical trials that touched the lives of over 15000 patients.
Today, Cromos Pharma has an extensive network of offices across 15 countries. These include Russia, Ukraine, Georgia and locations across Central and Eastern Europe including Hungary, Poland and Czech Republic. By moving our European HQ to Dublin, Ireland and establishing a strong US base the company has extended far beyond its regional beginnings and in the process has entirely transformed.
At the heart of Cromos Pharma’s development is a highly skilled and deeply committed team. They work tirelessly to expertly serve the needs of our valued clients. I can say that we are privileged to work with such a staff and that they will be central in further growth of Cromos Pharma.
Throughout our growth and expansion, our core vision has remained the same- accelerating the development of novel medicines and treatments that save lives. Patients remain at the core of Cromos Pharma’s mission.
As we celebrate 15 years, Cromos Pharma finds itself at a very exciting point in its development. With our growing US presence, we are poised to further our US client base and with our robust Dublin HQ we look forward to developing within Europe and beyond.
Cromos Pharma is ready to take our regional expertise and bring it to the next level, offering clients the great advantages of running trials in CIS and Eastern European countries while satisfying international regulations and standards.
We look forward to the next 15 years, as Cromos Pharma grows from a strong regional player to an even stronger global CRO!”
Vlad Bogin and Andrey Tarakanov
To learn more please watch this video
Cromos Pharma is pleased to share news about our latest project - an international double-blind placebo-controlled clinical trial of RPH-104 in acute ST-Elevation Myocardial Infarction (STEMI). The trial involving patients in the US and in Russia will investigate how a biologic RPH-104 developed by R-Pharm can reduce an acute inflammatory response after myocardial infarction and lead to improved outcomes for STEMI patients.
Throughout March we have been highlighting colorectal cancer, the amazing teams of researchers who are continuously fighting this disease, as well as the millions of patients and families who have been deeply affected by this silent killer. To close out this month of awareness-raising we want to introduce you to a real-life hero and colon cancer survivor - Arlene.
March is Colorectal Cancer Awareness Month. Colorectal cancer (CRC) is the third most common and second most deadly cancer worldwide according to 2020 figures from the Global Cancer Observatory.
Ukraine, the eight largest European country by population, is an attractive location for sponsors conducting clinical research for a number of key reasons. Cromos Pharma has been successfully managing clinical trials in Ukraine since 2006. This article looks at just some of the benefits of locating your next study here.
Cromos Pharma is continuously developing and looking to explore new territories when it comes to clinical research. In line with this spirit of discovery, we will be shortly commencing a new project in Uzbekistan supporting a study being conducted by the Swiss Tropical and Public Health Institute.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.